Biology Reference
In-Depth Information
Mehra MR (2006) Contemporary concepts in prevention and treatment of cardiac allograft
vasculopathy. Am J Transplant 6:1248-1256
Melnick JL, Adam E, Debakey ME (1993) Cytomegalovirus and atherosclerosis. Eur Heart
J 14:30-38
Melnychuk RM, Smith P, Kreklywich CN, Ruchti F, Vomaske J, Hall L, Loh L, Nelson JA, Orloff
SL, Streblow DN (2005) Mouse cytomegalovirus M33 is necessary and sufficient in virus-
induced vascular smooth muscle cell migration. J Virol 79:10788-10795
Messerle M, Hahn G, Brune W, Koszinowski UH (2000) Cytomegalovirus bacterial artificial
chromosomes: a new herpesvirus vector approach. Adv Virus Res 55:463-478
Meyers JD, Flournoy N, Thomas ED (1982) Nonbacterial pneumonia after allogeneic marrow
transplantation: a review of ten years' experience. Rev Infect Dis 4:1119-1132
Meyers JD, Flournoy N, Thomas ED (1986) Risk factors for cytomegalovirus infection after
human marrow transplantation. J Infect Dis 153:478-488
Minamishima I, Ueda K, Minematsu T, Minamishima Y, Umemoto M, Take H, Kuraya K (1994)
Role of breast milk in acquisition of cytomegalovirus infection. Microbiol Immunol
38:549-552
Miron D, Brosilow S, Felszer K, Reich D, Halle D, Wachtel D, Eidelman AI, Schlesinger Y
(2005) Incidence and clinical manifestations of breast milk-acquired Cytomegalovirus
infection in low birth weight infants. J Perinatol 25:299-303
Mizuta M, Schuster MG (2005) Cytomegalovirus hepatitis associated with use of anti-tumor
necrosis factor-alpha antibody. Clin Infect Dis 40:1071-1072
MMWR (1997) Rubella and congenital rubella syndrome - United States, 1994-1997. MMWR
Morb Mortal Wkly Rep 46:350-354
Moreno TN, Fortunato EA, Hsia K, Spector SA, Spector DH (1997) A model system for human
cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal
repeat activity in brain cells. J Virol 71:3693-3701
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001)
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Annu Rev Immunol 19:197-223
Morris DJ, Martin S, Dyer PA, Hunt L, Mallick NP, Johnson RW (1993) HLA mismatching and
cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal
allograft recipients. J Med Virol 41:324-327
Mueller C, Hodgson JM, Bestehorn HP, Brutsche M, Perruchoud AP, Marsch S, Roskamm H,
Buettner HJ (2003) Previous cytomegalovirus infection and restenosis after aggressive
angioplasty with provisional stenting. J Interv Cardiol 16:307-313
Muhlemann K, Miller RK, Metlay L, Menegus MA (1992) Cytomegalovirus infection of the
human placenta: an immunocytochemical study. Hum Pathol 23:1234-1237
Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, Anderson JL (2000)
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predic-
tive value for mortality in patients with angiographically demonstrated coronary artery disease.
Circulation 102:1917-1923
Munks MW, Pinto AK, Doom CM, Hill AB (2007) Viral interference with antigen presentation
does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus
infection. J Immunol 178:7235-7241
Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Nelson JA, Myers RM, Shenk
TE (2003) Coding capacity of laboratory and clinical strains of human cytomegalovirus. Proc
Natl Acad Sci USA 100:14976-14981
Murray BM, Subramaniam S (2004) Late cytomegalovirus infection after oral ganciclovir
prophylaxis in renal transplant recipients. Transpl Infect Dis 6:3-9
Myerson D, Hackman RC, Nelson JA et al (1984) Widespread presence of histologically occult
cytomegalovirus. Hum Pathol 15:430-439
Nerheim PL, Meier JL, Vasef MA, Li WG, Hu L, Rice JB, Gavrila D, Richenbacher WE,
Weintraub NL (2004) Enhanced cytomegalovirus infection in atherosclerotic human blood
vessels. Am J Pathol 164:589-600
